
Vellmika 250mg Injection
Marketer
Vellinton Healthcare
Salt Composition
Amikacin (250mg)
Overview Vellmika 250mg Injection
The antibiotic injection Vellmika 250mg combats a broad spectrum of bacterial infections, encompassing urinary tract, bone, joint, lung (such as pneumonia), brain, and bloodstream infections. Prophylactic use in hospitalized patients is also indicated. Its mechanism involves bacterial growth inhibition. Administered intravenously (drip) or via intramuscular/intravenous injection by a healthcare professional only, it necessitates regular, evenly-spaced dosing as directed. Complete the prescribed course, regardless of symptom improvement; premature cessation risks relapse or infection exacerbation. Typical adverse effects involve injection site reactions and elevated blood urea nitrogen. Persistent side effects or treatment inefficacy warrant medical consultation. High doses may rarely cause vertigo, nephrotoxicity, and ototoxicity. Strict adherence to physician instructions is crucial, potentially including regular kidney, hearing, and urine tests. Pregnancy contraindicates its use; disclose pregnancy, pregnancy planning, or breastfeeding to your doctor.
Primary Ingredients of Vellmika 250mg Injection
No information provided. Please provide the text you wish to be rewritten.
Uses of Vellmika 250mg Injection
Infections caused by bacteria
Major Benefits of Vellmika 250mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Vellmika 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Vellmika 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Vellmika 250mg Injection works:
Vellmika 250mg Injection is a bacterial growth inhibitor, a type of antibiotic. Its mechanism of action involves disrupting the production of vital bacterial proteins, thereby hindering essential bacterial processes.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Vellmika 250mg Injection poses no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Vellmika 250mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Vellmika, 250mg dose, is considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.
DrivingUNSAFE
Administering Vellmika 250mg Injection can lead to drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects manifest.
KidneyCAUTION
Exercise caution when administering Vellmika 250mg Injection to individuals with impaired kidney function. A modified dosage of Vellmika 250mg Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Vellmika 250mg Injection appears to pose minimal risk for individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Vellmika 250mg Injection :
Omit a scheduled Vellmika 250mg Injection? Seek your physician's advice.
Facts to Know About Vellmika 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
| Behavior Class | Aminoglycoside antibiotics |
